Chinese Multiple Dose Escalation (MDE) High Dose Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
A Phase 1 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Cotadutide in Overweight/Obese Subjects with Chinese ancestry with Type 2 Diabetes Mellitus
Epistemonikos ID: cb02aff319d7732930ef2b4a533fc1f530ae91db
First added on: May 13, 2024